Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$65.00
Provider: Wright Reports
$35.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Yafarm Technologies Inc Completes Acquisition Of Integrative Stem Cell Institute; Announces Resignation Of CEO And President


Tuesday, 21 May 2013 07:30am EDT 

Yafarm Technologies Inc announced the completion of its acquisition of the Integrative Stem Cell Institute (the ISCI). The new company, to be called the Integrative Stem Cell Institute, will continue the pioneering work of the ISCI in the field of cell-based regenerative medicine. The new company will provide point-of-care therapies based upon cell-based, regenerative medicine. The company will focus on the treatment of patients with limited or no options, and who suffer from diseases for which current medicine provides little or no alleviation. The ISCI combines ISO 7 laboratory with cell-based treatments and nutritional, occupational, physical and hyperbaric oxygen therapies to provide a unique and highly integrative medical approach. As a result of the transaction, Brian Hermenze and Cody McDowell have resigned from the Board and as President and Chief Executive Officer. Dr. Juan Casteel, Elizabeth Casteel, and David Kugelman have been appointed to the Board of Directors. 

Latest Developments for Intergrative Stem Cell Holdings Inc

Company Quote

0.0021
-0.0011 -34.38%
27 Jun 2014